In Response to Arcidiacono et al.: "Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?".

Show more authors
+ 1
Saskia A Cooke
Jan-Jakob Sonke
José S A Belderbos
Dirk de Ruysscher

More about this publication

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Volume 185
Pages 109690
Publication date 01-08-2023

Full text links

Publisher website (DOI) 10.1016/j.radonc.2023.109690
Europe PubMed Central 37164108
Pubmed 37164108

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.